The Extended-Release Revolution: How Formulation Advancements are Redefining Patient Compliance and Market Dynamics in the Venlafaxine Landscape
The evolution of the Venlafaxine market is inextricably linked to the success of its formulation advancements, particularly the widespread adoption and market dominance of the Extended-Release (ER) capsules. This shift from immediate-release tablets represents a 'revolution' in patient care, as ER technology addresses one of the most critical hurdles in long-term antidepressant treatment:...
0 Commentaires 0 Parts 628 Vue 0 Aperçu